Skip to content

CASI Pharmaceuticals, Inc.

CASIF· OTCCore metricsCIK 1962738

Pharmaceutical preparations552 peers

Close
May 15, 2026 · +7.14%
Market cap
$3.08M
20.56M shares
Filings
157
$20.71M
FY 2025−27.4% FY25 yoy
-$48.06M
FY 2025N/M FY25 yoy
-$45.01M
FY 2025N/M FY25 yoy
-$20.77M
FY 2025derivedN/M FY25 yoy
-$2.59
FY 2025N/M FY25 yoy
$5.63M
FY 2025−58.2% FY25 yoy
$3.08M
—
0.1×
—
-673.61%
—

FY2025 figures · derived

Price

$0.1592.35%$1.81past year
May 15, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$20.71MFY 2025
$38.05M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$20,712,000reported
FY 20242024-12-31$28,537,000reported
FY 20232023-12-31$33,879,000reported
FY 20222022-12-31$38,047,000reported
FY 20212021-12-31$30,020,000reported
FY 20202020-12-31$15,001,000reported

Capital returns

Dividends and buybacks · FY2022 to FY2023
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2023—$278.00K$278.00K—13.38M sh−0.6%—
FY2022—$3.27M$3.27M—13.46M sh−3.7%—

Pharmaceutical preparations

CASI Pharmaceuticals, Inc. is the 152nd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

CASI Pharmaceuticals, Inc. · CIK 1962738 · Engraved from SEC EDGAR